Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
IfOnlyYouKnew
on March 19, 2021
|
parent
|
context
|
favorite
| on:
In a Phase III trial, Proxalutamide reduced mortal...
I believe the trial data is from summer 2020? Survival rates of hospitalized patients improved dramatically over time.
Consider applying for YC's Summer 2026 batch! Applications are open till May 4
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
